121 related articles for article (PubMed ID: 17159032)
1. Early paracentral visual field loss in patients taking hydroxychloroquine.
Elder M; Rahman AM; McLay J
Arch Ophthalmol; 2006 Dec; 124(12):1729-33. PubMed ID: 17159032
[TBL] [Abstract][Full Text] [Related]
2. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
3. Screening for hydroxychloroquine toxicity.
Bienfang DC
Arch Ophthalmol; 2007 Nov; 125(11):1585; author reply 1585. PubMed ID: 17998532
[No Abstract] [Full Text] [Related]
4. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
[TBL] [Abstract][Full Text] [Related]
5. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
6. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
Maturi RK; Yu M; Weleber RG
Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
[TBL] [Abstract][Full Text] [Related]
7. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
[TBL] [Abstract][Full Text] [Related]
8. Comparison of screening procedures in hydroxychloroquine toxicity.
Marmor MF
Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine retinopathy after short-term therapy.
Phillips BN; Chun DW
Retin Cases Brief Rep; 2014; 8(1):67-9. PubMed ID: 25372212
[TBL] [Abstract][Full Text] [Related]
10. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
[TBL] [Abstract][Full Text] [Related]
11. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
Lyons JS; Severns ML
Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
[TBL] [Abstract][Full Text] [Related]
12. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
Browning DJ
Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
[TBL] [Abstract][Full Text] [Related]
13. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
[TBL] [Abstract][Full Text] [Related]
14. Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity.
Martínez-Costa L; Victoria Ibañez M; Murcia-Bello C; Epifanio I; Verdejo-Gimeno C; Beltrán-Catalán E; Marco-Ventura P
Can J Ophthalmol; 2013 Oct; 48(5):400-5. PubMed ID: 24093187
[TBL] [Abstract][Full Text] [Related]
15. Value of red targets and pattern deviation plots in visual field screening for hydroxychloroquine retinopathy.
Marmor MF; Chien FY; Johnson MW
JAMA Ophthalmol; 2013 Apr; 131(4):476-80. PubMed ID: 23710501
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine screening practice patterns within a large multispecialty ophthalmic practice.
Au A; Parikh V; Modi YS; Ehlers JP; Schachat AP; Singh RP
Am J Ophthalmol; 2015 Sep; 160(3):561-568.e2. PubMed ID: 26116260
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine dosages should be calculated using lean body mass.
Pautler SE
Arch Ophthalmol; 2007 Sep; 125(9):1303-4; author reply 1304. PubMed ID: 17846384
[No Abstract] [Full Text] [Related]
18. Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy.
Lai TY; Ngai JW; Chan WM; Lam DS
Doc Ophthalmol; 2006 May; 112(3):177-87. PubMed ID: 16804707
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
So SC; Hedges TR; Schuman JS; Quireza ML
Ophthalmic Surg Lasers Imaging; 2003; 34(3):251-8. PubMed ID: 12757106
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a follow-up protocol for patients on chloroquine and hydroxychloroquine treatment.
Sanabria MR; Toledo-Lucho SC
Arch Soc Esp Oftalmol; 2016 Jan; 91(1):10-4. PubMed ID: 26627497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
